$2,068,411
Former President/Ceo RSFH
2024
$2.1M related
--
$12k other
--
Former President/Ceo RSFH at Clinical Biotechnology Research Institute at RSFH
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Jeffrey Dilisi has been listed as an employee of Clinical Biotechnology Research Institute at RSFH in Form 990 filings since fiscal year 2024.